Hydrogen sulfide attenuates hyperhomocysteinemia-induced blood-brain barrier permeability by inhibiting MMP-9

References

• Kumar M, Sandhir R, Modi M. Hydrogen sulfide attenuates homocysteine-induced cognitive deficits and neurochemical alterations by improving endogenous hydrogen sulfide levels. Biofactors. 2017;43(3):434–450.
   PubMed Web of Science ®Google Scholar
• Kumar M, Sandhir R. Hydrogen sulfide in physiological and pathological mechanisms in brain. CNS Neurol Disord Drug Targets. 2018;17(9):654–670.
   PubMed Web of Science ®Google Scholar
• Kumar M, Mahajan A, Sapehia D, et al. Effects of altered maternal folate and vitamin B12 on neurobehavioral outcomes in F1 male mice. Brain Res Bull. 2019;153:93–101.
   PubMed Web of Science ®Google Scholar
• Kumar M, Goudihalli S, Mukherjee K, et al. Methylenetetrahydrofolate reductase C677T variant and hyperhomocysteinemia in subarachnoid hemorrhage patients from India. Metab Brain Dis. 2018;33(5):1617–1624.
   PubMed Web of Science ®Google Scholar
• Beard RS, Bearden SE, Bearden SE. Vascular complications of cystathionine β-synthase deficiency: future directions for homocysteine-to-hydrogen sulfide research. Am J Physiol Heart Circ Physiol. 2011;300(1):H13–26.
   PubMed Web of Science ®Google Scholar
• Licking N, Murchison C, Cholerton B, et al. Homocysteine and cognitive function in Parkinson’s disease. Parkinsonism Relat Disord. 2017;44:1–5.
   PubMed Web of Science ®Google Scholar
• Miller JW. Homocysteine and Alzheimer’s disease. Nutr Rev. 1999;57:126–129.
   PubMed Web of Science ®Google Scholar
• Polito L, Poloni TE, Vaccaro R, et al. High homocysteine and epistasis between MTHFR and APOE: association with cognitive performance in the elderly. Exp Gerontol. 2016;76:9–16.
   PubMed Web of Science ®Google Scholar
• Daneman R, Prat A. The blood-brain barrier. Cold Spring Harb Perspect Biol. 2015;7(1):a020412
   PubMed Web of Science ®Google Scholar
• Sweeney MD, Sagare AP, Zlokovic BV. Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders. Nat Rev Neurol. 2018;14(3):133–150.
   PubMed Web of Science ®Google Scholar
• Dayal S, Lentz SR. Murine models of hyperhomocysteinemia and their vascular phenotypes. Arterioscler Thromb Vasc Biol. 2008;28(9):1596–1605.
   PubMed Web of Science ®Google Scholar
• Li J-G, Praticò D. High levels of homocysteine results in cerebral amyloid angiopathy in mice. J Alzheimers Dis. 2015;43(1):29–35.
   PubMed Web of Science ®Google Scholar
• Rhodehouse BC, Mayo JN, Beard RS, et al. Opening of the blood-brain barrier before cerebral pathology in mild hyperhomocysteinemia. PLoS One. 2013;8(5):e63951.
   PubMed Web of Science ®Google Scholar
• Wu Y, Yang X, Li X, et al. Elevated cerebrospinal fluid homocysteine is associated with blood-brain barrier disruption in amyotrophic lateral sclerosis patients. Neurol Sci. 2020. 2020;41(7):1865–1872..
   PubMed Web of Science ®Google Scholar
• Qiu LH, Zhang BQ, Lian MJ, et al. Vascular protective effects of Astragalus membranaceus and its main constituents in rats with chronic hyperhomocysteinemia. Exp Ther Med. 2017;14(3):2401–2407.
   PubMed Web of Science ®Google Scholar
• Weekman EM, Woolums AE, Sudduth TL, et al. Hyperhomocysteinemia-Induced Gene Expression Changes in the Cell Types of the Brain. ASN Neuro. 2017;9(6):1759091417742296.
   Web of Science ®Google Scholar
• Kalani A, Kamat PK, Familtseva A, et al. Role of microRNA29b in blood-brain barrier dysfunction during hyperhomocysteinemia: an epigenetic mechanism. J Cereb Blood Flow Metab. 2014;34(7):1212–1222.
   PubMed Web of Science ®Google Scholar
• Lehmann M, Regland B, Blennow K, et al. Vitamin B12-B6-folate treatment improves blood-brain barrier function in patients with hyperhomocysteinaemia and mild cognitive impairment. Dement Geriatr Cogn Disord. 2003;16(3):145–150.
   PubMed Web of Science ®Google Scholar
• Kalani A, Kamat PK, Givvimani S, et al. Nutri-epigenetics Ameliorates blood-brain barrier damage and neurodegeneration in hyperhomocysteinemia: role of folic acid. J Mol Neurosci. 2014;52(2):202–215.
   PubMed Web of Science ®Google Scholar
• Rempe RG, Hartz AMS, Bauer B. Matrix metalloproteinases in the brain and blood-brain barrier: Versatile breakers and makers. J Cereb Blood Flow Metab. 2016;36(9):1481–1507.
   PubMed Web of Science ®Google Scholar
• Shefa U, Kim D, Kim M-S, et al. Roles of Gasotransmitters in Synaptic Plasticity and Neuropsychiatric Conditions. Neural Plast. 2018;2018:1824713–1824715.
   PubMed Web of Science ®Google Scholar
• Gerő D, Torregrossa R, Perry A, et al. The novel mitochondria-targeted hydrogen sulfide (H2S) donors AP123 and AP39 protect against hyperglycemic injury in microvascular endothelial cells in vitro. Pharmacol Res. 2016;113(Pt A):186–198.
   PubMed Web of Science ®Google Scholar
• Jiang Z, Li C, Manuel ML, et al. Role of hydrogen sulfide in early blood-brain barrier disruption following transient focal cerebral ischemia. PLoS One. 2015;10(2):e0117982
   PubMed Web of Science ®Google Scholar
• Geng Y, Li E, Mu Q, et al. Hydrogen sulfide inhalation decreases early blood-brain barrier permeability and brain edema induced by cardiac arrest and resuscitation. J Cereb Blood Flow Metab. 2015;35(3):494–500.
   PubMed Web of Science ®Google Scholar
• Cao S, Zhu P, Yu X, et al. Hydrogen sulfide attenuates brain edema in early brain injury after subarachnoid hemorrhage in rats: possible involvement of MMP-9 induced blood-brain barrier disruption and AQP4 expression. Neurosci Lett. 2016;621:88–97.
   PubMed Web of Science ®Google Scholar
• Mun J, Kang H-M, Park JJ. C. Role of hydrogen sulfide in cerebrovascular alteration during aging. Arch Pharm Res. 2019;42:446–454.
   PubMed Web of Science ®Google Scholar
• Kumar M, Sandhir R. Hydrogen sulfide attenuates hyperhomocysteinemia-induced mitochondrial dysfunctions in brain. Mitochondrion. 2020;50:158–169.
   PubMed Web of Science ®Google Scholar
• Kumar M, Sandhir R. Hydrogen sulfide suppresses homocysteine-induced glial activation and inflammatory response. Nitric Oxide. 2019;90:15–28.
   PubMed Web of Science ®Google Scholar
• Kumar M, Sandhir R. Neuroprotective Effect of Hydrogen Sulfide in Hyperhomocysteinemia Is Mediated Through Antioxidant Action Involving Nrf2. Neuromolecular Med. 2018;20(4):475–490.
   PubMed Web of Science ®Google Scholar
• Kumar M, Ray RS, Sandhir R. Hydrogen sulfide attenuates homocysteine-induced neurotoxicity by preventing mitochondrial dysfunctions and oxidative damage: In vitro and in vivo studies. Neurochem Int. 2018;120:87–98.
   PubMed Web of Science ®Google Scholar
• Scherer EBS, da Cunha AA, Kolling J, et al. Development of an animal model for chronic mild hyperhomocysteinemia and its response to oxidative damage. Int J Dev Neurosci. 2011;29(7):693–699.
   PubMed Web of Science ®Google Scholar
• Kang SS, Wong PWK, Malinow MR. Hyperhomocyst(e)inemia as a Risk Factor for Occlusive Vascular Disease. Annu Rev Nutr. 1992;12:279–298.
   PubMed Web of Science ®Google Scholar
• Morrey JD, Olsen AL, Siddharthan V, et al. Increased blood-brain barrier permeability is not a primary determinant for lethality of West Nile virus infection in rodents. J Gen Virol. 2008;89(Pt 2):467–473.
   PubMed Web of Science ®Google Scholar
• Weissman D, Stewart C. Experimental drug therapy of peritumoral brain edema. J Neurooncol. 1988;6(4):339–342.
   PubMed Web of Science ®Google Scholar
• Hoda MN, Singh I, Singh AK, et al. Reduction of lipoxidative load by secretory phospholipase A2 inhibition protects against neurovascular injury following experimental stroke in rat. J Neuroinflammation. 2009;6:21
   PubMed Web of Science ®Google Scholar
• Vandooren J, Geurts N, Martens E, et al. Gelatin degradation assay reveals MMP-9 inhibitors and function of O-glycosylated domain. World J Biol Chem. 2011;2(1):14–24.
   PubMedGoogle Scholar
• Brooks TA, Hawkins BT, Huber JD, et al. Chronic inflammatory pain leads to increased blood-brain barrier permeability and tight junction protein alterations. Am J Physiol Heart Circ Physiol. 2005;289(2):H738–43.
   PubMed Web of Science ®Google Scholar
• Hung Y-C, Chen T-Y, Lee E-J, et al. Melatonin decreases matrix metalloproteinase-9 activation and expression and attenuates reperfusion-induced hemorrhage following transient focal cerebral ischemia in rats. J Pineal Res. 2008;45(4):459–467.
   PubMed Web of Science ®Google Scholar
• Zhang JW, Gottschall PE. Zymographic measurement of gelatinase activity in brain tissue after detergent extraction and affinity-support purification. J Neurosci Methods. 1997;76(1):15–20.
   PubMed Web of Science ®Google Scholar
• Lowry OH, Rosebrough NJ, Farr AL, et al. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193(1):265–275.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25(4):402–408.
   PubMed Web of Science ®Google Scholar
• Cho K, Amin ZM, An J, Rambaran KA, et al. Methylenetetrahydrofolate Reductase A1298C polymorphism and major depressive disorder. Cureus. 2017;9(10):e1734.
   PubMed Web of Science ®Google Scholar
• Ford AH, Flicker L, Singh U, et al. Homocysteine, depression and cognitive function in older adults. J Affect Disord. 2013;151(2):646–651.
   PubMed Web of Science ®Google Scholar
• McCully KS. Review: chemical pathology of homocysteine VI. Aging, cellular senescence, and mitochondrial dysfunction. Ann Clin Lab Sci. 2018;48(5):677–687.
   PubMed Web of Science ®Google Scholar
• Smith AD, Refsum H. Homocysteine, B vitamins, and cognitive impairment. Annu Rev Nutr. 2016;36:211–239.
   PubMed Web of Science ®Google Scholar
• Sharma M, Tiwari M, Tiwari RK. Hyperhomocysteinemia: impact on Neurodegenerative Diseases. Basic Clin Pharmacol Toxicol. 2015;117(5):287–296.
   PubMed Web of Science ®Google Scholar
• Bonetti F, Brombo G, Zuliani G. The relationship between hyperhomocysteinemia and neurodegeneration. Neurodegener Dis Manag. 2016;6(2):133–145.
   PubMed Web of Science ®Google Scholar
• Trabetti E. Homocysteine, MTHFR gene polymorphisms, and cardio-cerebrovascular risk . J Appl Genet. 2008;49(3):267–282.
   PubMed Web of Science ®Google Scholar
• Obeid R, Herrmann W. Mechanisms of homocysteine neurotoxicity in neurodegenerative diseases with special reference to dementia. FEBS Lett. 2006;580(13):2994–3005.
   PubMed Web of Science ®Google Scholar
• Kumar M, Arora P, Sandhir R. Hydrogen sulfide reverses LPS-induced behavioral deficits by suppressing microglial activation and promoting M2 polarization. J Neuroimmune Pharmacol. 2020.DOI:10.1007/s11481-020-09920-z
   Web of Science ®Google Scholar
• Tyagi N, Moshal KS, Sen U, et al. H2S protects against methionine-induced oxidative stress in brain endothelial cells. Antioxid Redox Signal. 2009;11(1):25–33.
   PubMed Web of Science ®Google Scholar
• Shen Y, Guo W, Wang Z, et al. Protective effects of hydrogen sulfide in hypoxic human umbilical vein endothelial cells: a possible mitochondria-dependent pathway. Int J Mol Sci. 2013;14(7):13093–13108.
   PubMed Web of Science ®Google Scholar
• Szczesny B, Módis K, Yanagi K, et al. AP39, a novel mitochondria-targeted hydrogen sulfide donor, stimulates cellular bioenergetics, exerts cytoprotective effects and protects against the loss of mitochondrial DNA integrity in oxidatively stressed endothelial cells in vitro. Nitric Oxide. 2014;41:120–130.
   PubMed Web of Science ®Google Scholar
• Sweeney MD, Zhao Z, Montagne A, et al. Blood-brain barrier: From physiology to disease and back. Physiol Rev. 2019;99(1):21–78.
   PubMed Web of Science ®Google Scholar
• Rosenberg GA. Neurological diseases in relation to the blood-brain barrier. J Cereb Blood Flow Metab. 2012;32(7):1139–1151.
   PubMed Web of Science ®Google Scholar
• Ehrlich D, Humpel C. Chronic vascular risk factors (cholesterol, homocysteine, ethanol) impair spatial memory, decline cholinergic neurons and induce blood-brain barrier leakage in rats in vivo. J Neurol Sci. 2012;322(1–2):92–95.
   PubMed Web of Science ®Google Scholar
• Kaya M, Ahishali B. Assessment of permeability in barrier type of endothelium in brain using tracers: evans blue, sodium fluorescein, and horseradish peroxidase. Methods Mol Biol. 2011;763:369–382.
   PubMedGoogle Scholar
• Beard RS, Reynolds JJ, Bearden SE. Hyperhomocysteinemia increases permeability of the blood-brain barrier by NMDA receptor-dependent regulation of adherens and tight junctions. Blood. 2011;118(7):2007–2014.
   PubMed Web of Science ®Google Scholar
• Wang Y, Jia J, Ao G, et al. Hydrogen sulfide protects blood-brain barrier integrity following cerebral ischemia. J Neurochem. 2014;129(5):827–838.
   PubMed Web of Science ®Google Scholar
• Xu K, Wu F, Xu K, et al. NaHS restores mitochondrial function and inhibits autophagy by activating the PI3K/Akt/mTOR signalling pathway to improve functional recovery after traumatic brain injury. Chem Biol Interact. 2018;286:96–105.
   PubMed Web of Science ®Google Scholar
• Wang H, Wu Y, Han W, et al. Hydrogen sulfide ameliorates blood-spinal cord barrier disruption and improves functional recovery by inhibiting endoplasmic reticulum stress-dependent autophagy. Front Pharmacol. 2018;9 (article number: 858).
   Google Scholar
• Stokum JA, Kurland DB, Gerzanich V, et al. Mechanisms of astrocyte-mediated cerebral edema. Neurochem Res. 2015;40(2):317–328.
   PubMed Web of Science ®Google Scholar
• Filippidis A, Carozza R, Rekate H. Aquaporins in brain edema and neuropathological conditions. Int J Mol Sci. 2016;18(1):55.
   Web of Science ®Google Scholar
• Assentoft M, Larsen BR, MacAulay N. Regulation and function of AQP4 in the central nervous system. Neurochem Res. 2015;40(12):2615–2627.
   PubMed Web of Science ®Google Scholar
• Wei X, Zhang B, Zhang Y, et al. Hydrogen sulfide inhalation improves neurological outcome via NF-κB-mediated inflammatory pathway in a rat model of cardiac arrest and nd resuscitation. Cell Physiol Biochem. 2015;36(4):1527–1538.
   PubMedGoogle Scholar
• Sporer B, Koedel U, Paul R, et al. Human immunodeficiency virus type-1 Nef protein induces blood-brain barrier disruption in the rat: role of matrix metalloproteinase-9. J Neuroimmunol. 2000;102(2):125–130.
   PubMed Web of Science ®Google Scholar
• Fujimura M, Gasche Y, Morita-Fujimura Y, et al. Early appearance of activated matrix metalloproteinase-9 and blood-brain barrier disruption in mice after focal cerebral ischemia and reperfusion. Brain Res. 1999;842(1):92–100.
   PubMed Web of Science ®Google Scholar
• Rosenberg GA. Matrix metalloproteinases in brain injury. J Neurotrauma. 1995;12(5):833–842.
   PubMed Web of Science ®Google Scholar
• Okamoto T, Akuta T, Tamura F, et al. Molecular mechanism for activation and regulation of matrix metalloproteinases during bacterial infections and respiratory inflammation. Biol Chem. 2004;385(11):997–1006.
   PubMed Web of Science ®Google Scholar
• Yu F, Kamada H, Niizuma K, et al. Induction of mmp-9 expression and endothelial injury by oxidative stress after spinal cord injury. J Neurotrauma. 2008;25(3):184–195.
   PubMed Web of Science ®Google Scholar
• Nath N, Prasad HK, Kumar M. Cerebroprotective effects of hydrogen sulfide in homocysteine-induced neurovascular permeability: involvement of oxidative stress, arginase, and matrix metalloproteinase-9. J Cell Physiol. 2019;234(3):3007–3019.
   PubMed Web of Science ®Google Scholar
• Kunisawa K, Nakashima N, Nagao M, et al. Betaine prevents homocysteine-induced memory impairment via matrix metalloproteinase-9 in the frontal cortex. Behav Brain Res. 2015;292:36–43.
   PubMed Web of Science ®Google Scholar
• Fanjul-Fernández M, Folgueras AR, Cabrera S, et al. Matrix metalloproteinases: evolution, gene regulation and functional analysis in mouse models. Biochim Biophys Acta. 2010;1803(1):3–19.
   PubMed Web of Science ®Google Scholar
• Könnecke H, Bechmann I. The role of microglia and matrix metalloproteinases involvement in neuroinflammation and gliomas. Clin Dev Immunol. 2013;2013:914104.
   PubMedGoogle Scholar
• Wang T, Liao Y, Sun Q, et al. Upregulation of matrix metalloproteinase-9 in primary cultured rat astrocytes induced by 2-chloroethanol via MAPK signal pathways. Front Cell Neurosci. 2017;11(218).
   Web of Science ®Google Scholar
• Kundu S, Pushpakumar SB, Tyagi A, et al. Hydrogen sulfide deficiency and diabetic renal remodeling: role of matrix metalloproteinase-9. Am J Physiol Endocrinol Metab. 2013;304(12):E1365–E1378.
   PubMed Web of Science ®Google Scholar
• Li H, Zhu L, Feng J, et al. Hydrogen sulfide decreases blood-brain barrier damage via regulating protein kinase C and tight junction after cardiac arrest in rats. Cell Physiol Biochem. 2018;47(3):994–1006.
   PubMedGoogle Scholar
• Tyagi N, Moshal KS, Sen U, et al. Ciglitazone ameliorates homocysteine-mediated mitochondrial translocation and matrix metalloproteinase-9 activation in endothelial cells by inducing peroxisome proliferator activated receptor-gamma activity. Cell Mol Biol (Noisy-Le. 2006;52:21–27. Grand).
   PubMed Web of Science ®Google Scholar
• Moshal KS, Zeldin DC, Sithu SD, et al. Cytochrome P450 (CYP) 2J2 gene transfection attenuates MMP-9 via inhibition of NF-kappabeta in hyperhomocysteinemia. J Cell Physiol. 2008;215(3):771–781.
   PubMed Web of Science ®Google Scholar
• Vacek TP, Gillespie W, Tyagi N, et al. Hydrogen sulfide protects against vascular remodeling from endothelial damage. Amino Acids. 2010;39(5):1161–1169.
   PubMed Web of Science ®Google Scholar
• Cai J, Shi X, Wang H, et al. Cystathionine γ lyase-hydrogen sulfide increases peroxisome proliferator-activated receptor γ activity by sulfhydration at C139 site thereby promoting glucose uptake and lipid storage in adipocytes . Biochim Biophys Acta. 2016;1861(5):419–429.
   PubMed Web of Science ®Google Scholar